Product Theater:
Lexeo Therapeutics

All Hypertrophy is Familiar, Until it Isn't: Friedreich Ataxia Cardiomyopathy & Addressing the Root Cause with AAV Gene Therapy

Friedreich ataxia cardiomyopathy (FA-CM) often presents with left ventricular hypertrophy familiar to HCM specialists, yet differs substantially in its underlying biology, disease trajectory, and unmet clinical needs. This product theater will explore FA-CM and discuss Lexeo's investigational adeno-associated virus (AAV) gene therapy program (LX2006) designed to target the root cause of the disease.